{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:05:24Z","timestamp":1787655924301,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Trauma Acute Care Surg"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>There is debate on the need to withhold chemical venous thromboembolism (VTE) prophylaxis in patients requiring major orthopedic surgery. We hypothesized that the incidence of clinically significant hemorrhage (CSH) does not differ by the timing of prophylaxis in such patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>This was a multicenter, retrospective cohort study conducted at five US trauma centers that included trauma patients admitted between January 1, 2018, to March 1, 2020, requiring surgical fixation of the femoral shaft, hip, or tibia and received VTE chemoprophylaxis during the hospitalization. Exclusions were major and moderate head or spinal injuries, chronic anticoagulant use, or multiple long bone surgeries. Timing of VTE chemoprophylaxis was examined as four groups: (1) initiated preoperatively without interruption for surgery; (2) initiated preoperatively but held perioperatively; (3) initiated within 12 hours postoperatively; and (4) initiated &gt;12 hours postoperatively. The primary outcome was incidence of CSH (%), defined as overt hemorrhage within 24 hours postoperative that was actionable. Multivariate logistic regression evaluated differences in CSH based on timing of VTE chemoprophylaxis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>There were 786 patients, and 65 (8.3%) developed a CSH within 24 hours postoperatively. Nineteen percent of patients received chemoprophylaxis preoperatively without interruption for surgery, 13% had preoperative initiation but dose(s) were held for surgery, 21% initiated within 12 hours postoperatively, and 47% initiated more than 12 hours postoperatively. The incidence and adjusted odds of CSH were similar across groups (11.3%, 9.1%, 7.1%, and 7.3% respectively; overall <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.60). The incidence of VTE was 0.9% and similar across groups (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.47); however, six of seven VTEs occurred when chemoprophylaxis was delayed or interrupted.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>This study suggests that early and uninterrupted VTE chemoprophylaxis is safe and effective in patients undergoing major orthopedic surgery for long bone fractures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LEVEL OF EVIDENCE<\/jats:title>\n            <jats:p>Therapeutic\/Care Management; Level IV.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ta.0000000000003773","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:24Z","timestamp":1661299224000},"page":"169-176","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Timing of venous thromboembolism chemoprophylaxis with major surgery of lower-extremity long bone fractures"],"prefix":"10.1097","volume":"94","author":[{"given":"Kristin","family":"Salottolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Carrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nnamdi","family":"Nwafo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Madayag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Corrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaysie","family":"Banton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bar-Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"issue":"2","key":"bib2-20250806","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","year":"2016","journal-title":"Chest"},{"issue":"4","key":"bib3-20250806","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1302\/2058-5241.3.170018","article-title":"Thromboembolism prophylaxis in orthopaedics: an update","volume":"3","year":"2018","journal-title":"EFORT Open Rev"},{"key":"bib4-20250806","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.artd.2021.06.015","article-title":"Time for an update? A look at current guidelines for venous thromboembolism prophylaxis after hip and knee arthroplasty and hip fracture","volume":"10","year":"2021","journal-title":"Arthroplast Today"},{"issue":"19","key":"bib5-20250806","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","year":"2020","journal-title":"Blood Adv"},{"key":"bib6-20250806","first-page":"e20200109","article-title":"Bleeding risk assessment for venous thromboembolism prophylaxis","volume":"20","year":"2021","journal-title":"J Vasc Bras"},{"issue":"11","key":"bib7-20250806","doi-asserted-by":"crossref","first-page":"893","DOI":"10.7326\/0003-4819-139-11-200312020-00007","article-title":"Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis","volume":"139","year":"2003","journal-title":"Ann Intern Med"},{"issue":"3","key":"bib8-20250806","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11239-013-0899-7","article-title":"Assessing bleeding risk in patients taking anticoagulants","volume":"35","year":"2013","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"bib9-20250806","doi-asserted-by":"crossref","first-page":"e000643","DOI":"10.1136\/tsaco-2020-000643","article-title":"Venous thromboembolism prophylaxis in the trauma intensive care unit: an American Association for the Surgery of Trauma Critical Care Committee clinical consensus document","volume":"6","year":"2021","journal-title":"Trauma Surg Acute Care Open"},{"issue":"13","key":"bib10-20250806","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/archinte.162.13.1451","article-title":"Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?","volume":"162","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"bib11-20250806","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00068-019-01208-z","article-title":"Venous thromboembolism (VTE) prophylaxis in severely injured patients: an international comparative assessment","volume":"47","year":"2021","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"1","key":"bib12-20250806","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1378\/chest.09-3081","article-title":"Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators","volume":"139","year":"2011","journal-title":"Chest"},{"key":"bib13-20250806","first-page":"1","article-title":"The effect of anti-thrombotics on the postoperative bleeding rate in patients undergoing craniotomy for brain tumor","year":"2021","journal-title":"Br J Neurosurg"},{"issue":"2","key":"bib14-20250806","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcot.2016.01.002","article-title":"Increased risk of adverse events in management of femur and tibial shaft fractures with plating: an analysis of NSQIP data","volume":"7","year":"2016","journal-title":"J Clin Orthop Trauma"},{"issue":"1","key":"bib15-20250806","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcot.2017.01.007","article-title":"The incidence of deep vein thrombosis and pulmonary embolism after fracture of the tibia: an analysis of the National Trauma Databank","volume":"8","year":"2017","journal-title":"J Clin Orthop Trauma"},{"issue":"5","key":"bib16-20250806","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/TA.0000000000001009","article-title":"Determining the magnitude of surveillance bias in the assessment of lower extremity deep venous thrombosis: a prospective observational study of two centers","volume":"80","year":"2016","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"bib17-20250806","first-page":"19","article-title":"Interrupted pharmocologic thromboprophylaxis increases venous thromboembolism in traumatic brain injury","volume":"70","year":"2011","journal-title":"J Trauma"},{"issue":"4","key":"bib18-20250806","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1097\/SLA.0000000000004349","article-title":"Association between missed doses of chemoprophylaxis and VTE incidence in a statewide colectomy cohort","volume":"273","year":"2021","journal-title":"Ann Surg"},{"issue":"4","key":"bib19-20250806","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamasurg.2013.3963","article-title":"Correlation of missed doses of enoxaparin with increased incidence of deep vein thrombosis in trauma and general surgery patients","volume":"149","year":"2014","journal-title":"JAMA Surg"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000003773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:11:21Z","timestamp":1754496681000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000003773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000003773","relation":{},"ISSN":["2163-0763","2163-0755"],"issn-type":[{"value":"2163-0763","type":"electronic"},{"value":"2163-0755","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,24]]}}}